Loading…
Held by equity mutual funds in 35 disclosed months, Nov 2023 to Sep 2026.
Piramal Pharma Limited (Pharmaceuticals & Biotechnology) was held by 32 active equity mutual funds in September 2026, ₹2,701 Cr in all (up 4 funds from Aug 2026). The largest position was Bajaj Finserv Healthcare Fund at 6.4% of its portfolio. During the month 7 funds entered and 3 exited. Funds have disclosed holding it since Nov 2023.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.